Interpreting Reported Risks Associated With Use of Proton Pump Inhibitors: Residual Confounding in a 10-Year Analysis of National Ambulatory Data

Gastroenterology. 2020 Feb;158(3):780-782.e3. doi: 10.1053/j.gastro.2019.10.023. Epub 2019 Oct 31.

¹ Department of Medicine, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada; Robarts Clinical Trials, Inc, London, Ontario, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
² Department of Medicine, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
³ Department of Medicine, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
⁴ Department of Medicine, Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada; Farncombe Family Digestive Health Research Institute, Hamilton, Ontario, Canada.
⁵ Department of Medicine, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. Electronic address: nauzer.forbes@ucalgary.ca.

No abstract available

Keywords: Bias; Drug therapy; Risk.

MeSH terms